ITGAX and neoplasm: Recruit lymphocytes and antigen-stimulated DCs, leading to increased infiltrates of CD4, CD8, and CD11c+DEC205+ dendritic cells in the tumor, creating a lymphoid-like microenvironment and facilitating cognate T cell activation.